COVID-19 – Changes to Lawley Pharmaceuticals operations
COVID-19 – Changes to Lawley Pharmaceuticals operations During large scale health crises, the continued supply of medicines is an essential service to the community. … Continue reading
TGA accepts Lawley product for evaluation in postmenopausal women with HSDD.
TGA accepts Lawley product for evaluation in postmenopausal women with HSDD. Perth, Western Australia; Dec. 05, 2019 — Lawley Pharmaceuticals Pty Ltd today announced … Continue reading
Gender disparity in sexual health options for women: Experts call on pharma and drug regulators to address
In 2015 Comment in the prestigious medical journal Lancet Diabetes & Endocrinology by two of the world’s leading female sexual health specialists, Prof. … Continue reading
Menopause specialists warn against dangers of “bioidentical hormones”
On Monday 15th July 2019 in a comprehensive interview on the Life Matters program (ABC Radio National) two of Australia’s premier menopause specialists, Dr Elizabeth Farrell and … Continue reading
BBC Menopause and testosterone replacement therapy
Over 900 specialist menopause physicians from around the world attended The European Menopause and Andropause Society conference held in Berlin on 15-17th May 2019. Numerous … Continue reading
Hypoactive Sexual Desire Disorder (HSDD) re-defined
In late 2018 the World Health Organisation (WHO) released an update to The International Classification of Disease (ICD). ICD is a system of medical coding created … Continue reading
Federal Court Proceedings Demonstrate Risk To Compounding Pharmacies
MEDIA RELEASE 3rd August 2017 A recent Federal Court case highlights the very real risk and cost to Compounding Pharmacies who do not … Continue reading
FDA releases Industry Guidance for Low Sexual Interest, Desire and/or Arousal in Women
In late October 2016 the US FDA released draft guidance for Industry on Low Sexual Interest, Desire, and/or Arousal in Women: Developing Drugs for Treatment. … Continue reading
Flibanserin, the drug that gives women one extra sexually satisfying experience every two months
Flibanserin, the drug that gives women one extra sexually satisfying experience every two months Continue reading
The Testosterone and Exercise (TEX) Trial
Status: Study completed October 2018. Analysis of results underway. The University of Western Australia and Fiona Stanley Hospital are now recruiting for the TEX … Continue reading
Participants Required For Men’s Testosterone Study
Professor David J Handelsman (Andrology Dept, Concord Hospital, ANZAC Research Institute, Sydney) is looking to recruit 15 healthy male volunteers to participate in a … Continue reading
Current Guidelines For Prescribing Testosterone On The PBS
The Pharmaceutical Benefits Advisory Committee announced new prescribing criteria for testosterone effective from the 1st of April 2015. The main changes that were made are … Continue reading
New Testosterone Cream for Women Study
Monash Women’s Health Research Centre (Melbourne) is seeking women to participate in a new study to determine the optimum application of a 1% testosterone … Continue reading
The World Menopause Congress 2014
The 14th World Menopause Congress was held in Cancun Mexico from May 1-4, 2014. There were numerous sessions covering female sexual health in the … Continue reading